The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Diabetic cardiomyopathy (DCM) is defined as the presence in diabetic patients of abnormal cardiac structure and performance (such as left ventricular hypertrophy, fibrosis, and arrhythmia) in the absence of other cardiac risk factors (such as hypertension or coronary artery disease). Although the pathogenesis of DCM remains unclear currently, mitochondrial structural and functional dysfunctions are recognised as a central player in the DCM development. In this review, we focus on the role of mitochondrial dynamics, biogenesis and mitophagy, Ca metabolism and bioenergetics in the DCM development and progression. Based on the crucial role of mitochondria in DCM, application of mitochondria-targeting therapies could be effective strategies to slow down the progression of the disease.
Li D, Zhang L, Gong Q, Deng H, Luo C, Zhou T Clin Epigenetics. 2025; 17(1):15.
PMID: 39865334 PMC: 11765930. DOI: 10.1186/s13148-025-01814-2.
Targeting mitochondrial transfer: a new horizon in cardiovascular disease treatment.
Zuo B, Li X, Xu D, Zhao L, Yang Y, Luan Y J Transl Med. 2024; 22(1):1160.
PMID: 39741312 PMC: 11687156. DOI: 10.1186/s12967-024-05979-x.
Molecular Basis of Cardiomyopathies in Type 2 Diabetes.
Giardinelli S, Meliota G, Mentino D, DAmato G, Faienza M Int J Mol Sci. 2024; 25(15).
PMID: 39125850 PMC: 11313011. DOI: 10.3390/ijms25158280.
Apigenin ameliorates genitourinary dysfunction in a type 1 diabetic rat model via Drp1 modulation.
Khaled M, Salama R, Aboughalia A, Tarek M, Fawzy N Sci Rep. 2024; 14(1):5754.
PMID: 38459102 PMC: 10924091. DOI: 10.1038/s41598-024-56395-6.
Sprason C, Tucker T, Clancy D Front Aging. 2024; 5:1359638.
PMID: 38425363 PMC: 10902006. DOI: 10.3389/fragi.2024.1359638.